Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

OGDHL Polyclonal antibody

OGDHL Polyclonal Antibody for WB, IHC, IP, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IHC, IF, IP, ELISA

2-oxoglutarate dehydrogenase complex component E1-like, 2-oxoglutarate dehydrogenase-like, mitochondrial, Alpha-ketoglutarate dehydrogenase-like, EC:1.2.4.2, KIAA1290

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for OGDHL in ?

Tested Applications

Positive WB detected inmouse brain tissue, mouse kidney tissue, rat brain tissue
Positive IP detected inmouse brain tissue
Positive IHC detected inhuman liver tissue, human pancreas cancer tissue, rat brain tissue, mouse liver tissue, mouse brain tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:10000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

17110-1-AP targets OGDHL in WB, IHC, IF, IP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag10794

Product name: Recombinant human OGDHL protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 661-1010 aa of BC026320

Sequence: SGQDVERGTFSHRHHVLHDQEVDRRTCVPMNHLWPDQAPYTVCNSSLSEYGVLGFELGYAMASPNALVLWEAQFGDFHNTAQCIIDQFISTGQAKWVRHNGIVLLLPHGMEGMGPEHSSARPERFLQMSNDDSDAYPAFTKDFEVSQLYDCNWIVVNCSTPANYFHVLRRQILLPFRKPLIIFTPKSLLRHPEAKSSFDQMVSGTSFQRVIPEDGAAARAPEQVQRLIFCTGKVYYDLVKERSSQDLEEKVAITRLEQISPFPFDLIKQEAEKYPGAELAWCQEEHKNMGYYDYISPRFMTILRRARPIWYVGRDPAAAPATGNRNTHLVSLKKFLDTAFNLQAFEGKTF

Predict reactive species
Full Name oxoglutarate dehydrogenase-like
Calculated Molecular Weight 1010 aa, 115 kDa
Observed Molecular Weight 115 kDa
GenBank Accession NumberBC026320
Gene Symbol OGDHL
Gene ID (NCBI) 55753
RRIDAB_2156767
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9ULD0
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

OGDHL(oxoglutarate dehydrogenase-like) is also named as KGDE1KL, FLJ10851, KIAA1290 and belongs to the alpha-ketoglutarate dehydrogenase family. OGDHL is one of the rate-limiting component of the multienzyme OGDH complex (OGDHC) whose malfunction is associated with neuro-degeneration and it is localized only in the mitochondrial fraction and not in the cytosolic or nuclear fractions(PMID:23152800). OGDHL negatively regulates cell proliferation by inducing apoptosis in cervical cancer cells. It may thus participate in brain-specific control of 2-oxoglutarate distribution between energy production and synthesis of the neurotransmitter glutamate(PMID:18783430). It has 3 isoforms(114 kDa, 108 kDa, 91 kDa) produced by alternative splicing.

Protocols

Product Specific Protocols
IHC protocol for OGDHL antibody 17110-1-APDownload protocol
IP protocol for OGDHL antibody 17110-1-APDownload protocol
WB protocol for OGDHL antibody 17110-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The anti-OGDHL antibody (Cat# 17110-1-AP) has 19 citations across journals including Nature Communications, Journal of Hepatology, Cell Death & Differentiation, American Journal of Human Genetics, Journal of Experimental Medicine, Metabolism, and Cancer Science. Research fields span hepatocellular carcinoma, Parkinson's disease, neurodevelopmental disorders, Alzheimer's disease, gastric cancer, glioblastoma, cardiac disease, depression/anxiety, mitochondrial metabolism, and stem cell differentiation.

SpeciesApplicationTitle
humanWB

J Hepatol

OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.

Authors - Weiqi Dai
  • KD Validated
humanWB

Nat Commun

Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models

Authors - Ge Gao
humanWB

Nat Commun

A reversible state of hypometabolism in a human cellular model of sporadic Parkinson's disease

Authors - Sebastian Schmidt

Metabolism

Glutamine synthetase deficiency triggers mitochondrial oxidative stress and a ribotoxic stress response during acute hepatic metabolic crisis.

Authors - Guihua Jin
humanWB,IHC,IF

Cell Death Differ

Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function

Authors - Xiang Jiang
human

J Exp Med

CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis

Authors - Xiaozheng Xu
Loading...
||
New chat

Able™

正在加载,请稍候...